185 related articles for article (PubMed ID: 24086767)
21. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3.
Wu Z; Hoover DM; Yang D; Boulègue C; Santamaria F; Oppenheim JJ; Lubkowski J; Lu W
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8880-5. PubMed ID: 12840147
[TBL] [Abstract][Full Text] [Related]
22. Influence of disulfide bonds in human beta defensin-3 on its strain specific activity against Gram-negative bacteria.
Nehls C; Böhling A; Podschun R; Schubert S; Grötzinger J; Schromm A; Fedders H; Leippe M; Harder J; Kaconis Y; Gronow S; Gutsmann T
Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183273. PubMed ID: 32171739
[TBL] [Abstract][Full Text] [Related]
23. Influence of truncation of avian β-defensin-4 on biological activity and peptide-membrane interaction.
Dong N; Ma QQ; Shan AS; Wang L; Sun WY; Li YZ
Protein Pept Lett; 2012 Apr; 19(4):430-8. PubMed ID: 22316306
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial characterization of human beta-defensin 3 derivatives.
Hoover DM; Wu Z; Tucker K; Lu W; Lubkowski J
Antimicrob Agents Chemother; 2003 Sep; 47(9):2804-9. PubMed ID: 12936977
[TBL] [Abstract][Full Text] [Related]
25. Structure, dynamics, and activity of an all-cysteine mutated human beta defensin-3 peptide analogue.
Chandrababu KB; Ho B; Yang D
Biochemistry; 2009 Jul; 48(26):6052-61. PubMed ID: 19480463
[TBL] [Abstract][Full Text] [Related]
26. Single disulfide and linear analogues corresponding to the carboxy-terminal segment of bovine beta-defensin-2: effects of introducing the beta-hairpin nucleating sequence d-pro-gly on antibacterial activity and Biophysical properties.
Krishnakumari V; Sharadadevi A; Singh S; Nagaraj R
Biochemistry; 2003 Aug; 42(31):9307-15. PubMed ID: 12899617
[TBL] [Abstract][Full Text] [Related]
27. Human beta-defensins.
Pazgier M; Hoover DM; Yang D; Lu W; Lubkowski J
Cell Mol Life Sci; 2006 Jun; 63(11):1294-313. PubMed ID: 16710608
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.
Klüver E; Schulz-Maronde S; Scheid S; Meyer B; Forssmann WG; Adermann K
Biochemistry; 2005 Jul; 44(28):9804-16. PubMed ID: 16008365
[TBL] [Abstract][Full Text] [Related]
29. Chimeric analogs of human β-defensin 1 and θ-defensin disrupt pre-established bacterial biofilms.
Mathew B; Olli S; Guru A; Nagaraj R
Bioorg Med Chem Lett; 2017 Aug; 27(15):3264-3266. PubMed ID: 28642103
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations.
Lehrer RI; Ganz T; Szklarek D; Selsted ME
J Clin Invest; 1988 Jun; 81(6):1829-35. PubMed ID: 3290255
[TBL] [Abstract][Full Text] [Related]
31. Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S.
Lee DL; Powers JP; Pflegerl K; Vasil ML; Hancock RE; Hodges RS
J Pept Res; 2004 Feb; 63(2):69-84. PubMed ID: 15009528
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines.
Varkey J; Nagaraj R
Antimicrob Agents Chemother; 2005 Nov; 49(11):4561-6. PubMed ID: 16251296
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial properties of human beta defensin-3 derivative: CHRG01.
Arora A; Majhi S; Mishra A
J Biosci; 2018 Sep; 43(4):707-715. PubMed ID: 30207316
[TBL] [Abstract][Full Text] [Related]
34. A novel big defensin identified in horseshoe crab hemocytes: isolation, amino acid sequence, and antibacterial activity.
Saito T; Kawabata S; Shigenaga T; Takayenoki Y; Cho J; Nakajima H; Hirata M; Iwanaga S
J Biochem; 1995 May; 117(5):1131-7. PubMed ID: 8586631
[TBL] [Abstract][Full Text] [Related]
35. Effects of increasing hydrophobicity by N-terminal myristoylation on the antibacterial and hemolytic activities of the C-terminal cationic segments of human-β-defensins 1-3.
Krishnakumari V; Guru A; Adicherla H; Nagaraj R
Chem Biol Drug Des; 2018 Aug; 92(2):1504-1513. PubMed ID: 29682907
[TBL] [Abstract][Full Text] [Related]
36. Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1.
Schroeder BO; Wu Z; Nuding S; Groscurth S; Marcinowski M; Beisner J; Buchner J; Schaller M; Stange EF; Wehkamp J
Nature; 2011 Jan; 469(7330):419-23. PubMed ID: 21248850
[TBL] [Abstract][Full Text] [Related]
37. Effects of cations on antimicrobial activity of ostricacins-1 and 2 on E. coli O157:H7 and S. aureus 1056MRSA.
Sugiarto H; Yu PL
Curr Microbiol; 2007 Jul; 55(1):36-41. PubMed ID: 17554470
[TBL] [Abstract][Full Text] [Related]
38. Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides.
Vylkova S; Li XS; Berner JC; Edgerton M
Antimicrob Agents Chemother; 2006 Jan; 50(1):324-31. PubMed ID: 16377704
[TBL] [Abstract][Full Text] [Related]
39. Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids.
Xie C; Prahl A; Ericksen B; Wu Z; Zeng P; Li X; Lu WY; Lubkowski J; Lu W
J Biol Chem; 2005 Sep; 280(38):32921-9. PubMed ID: 15894545
[TBL] [Abstract][Full Text] [Related]
40. Human β-defensin 2 kills
Järvå M; Phan TK; Lay FT; Caria S; Kvansakul M; Hulett MD
Sci Adv; 2018 Jul; 4(7):eaat0979. PubMed ID: 30050988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
